---
category: neurology
aliases:
  - CGRP migraine
  - calcitonin gene related peptide
tags:
  - migraine
  - CGRP
  - pathophysiology
---

# CGRP in Migraine Pathophysiology

## Definition
**Calcitonin Gene-Related Peptide (CGRP)** is a neuropeptide that serves as a potent vasodilator and primary mediator in migraine pathophysiology.

## Key Functions
- **Nociceptive signaling**: Crucial for pain transmission
- **Vasodilation**: Potent vasodilatory effects
- **Central sensitization**: Contributes to hyperexcitability

## Clinical Significance

### Elevated Levels
- **During migraine attacks**: Significantly increased
- **Interictally in migraineurs**: Consistently elevated
- **Biomarker potential**: Key biological marker for migraine

### Therapeutic Target
CGRP is a **highly successful therapeutic target** with multiple drug classes:

## CGRP-Targeted Therapies

### 1. Monoclonal Antibodies (mAbs)
**Preventive treatment:**
- **Erenumab** (Aimovig)
- **Galcanezumab** (Emgality) 
- **Fremanezumab** (Ajovy)
- **Eptinezumab** (Vyepti)

**Administration**: Monthly or quarterly injections

### 2. Gepants (Oral CGRP Antagonists)
**Acute and preventive treatment:**
- **Rimegepant** (Nurtec)
- **Ubrogepant** (Ubrelvy)
- **Atogepant** (Qulipta)

**Advantages**:
- No vasoconstrictor activity
- Safer for cardiovascular risk patients
- Less rebound headache risk

## Clinical Evidence
- **INVESTMENT trial**: Demonstrated galcanezumab efficacy in reducing "definite dizzy days" in VM patients
- **Off-label use**: Effective for refractory Vestibular Migraine
- **Revolutionary impact**: Most significant advance in migraine therapy in decades

## Related Notes
- [[Modern Understanding of Migraine Pathophysiology]]
- [[CGRP Antagonist Therapies]]
- [[Vestibular Migraine Treatment]]
[[CGRP in Migraine Pathophysiology|CGRP migraine]]




























